Autolus Therapeutics plc

Four drugs with an orphan designation – Aucatzyl (obecabtagene autoleucel), Blenrep (belantamab mafodotin), Ezmekly (mirdametinib) and Maapliv (amino acids) – are among the 10 new products on track fo

The European Medicines Agency is this week deciding whether to recommend pan-EU marketing authorization for a number of new medicines, including obecabtagene autoleucel (obe-cel), Autolus Therapeutics

The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th

The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th